Ziebell Mark R 4
4 · Avid Bioservices, Inc. · Filed Apr 11, 2024
Insider Transaction Report
Form 4
Ziebell Mark R
VP and General Counsel
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value
2024-04-09+1,261→ 65,226 total - Exercise/Conversion
Restricted Stock Units
2024-04-09−1,251→ 34,866 total→ Common Stock (1,251 underlying) - Exercise/Conversion
Restricted Stock Units
2024-04-09−1,261→ 36,117 total→ Common Stock (1,261 underlying) - Exercise/Conversion
Restricted Stock Units
2024-04-09−696→ 37,378 total→ Common Stock (696 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2024-04-09+696→ 63,965 total - Exercise/Conversion
Common Stock, $0.001 par value
2024-04-09+1,251→ 66,477 total
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
- [F2]RSUs granted to the reporting person on July 9, 2021, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2021, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
- [F3]RSUs granted to the reporting person on July 9, 2022, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2022, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
- [F4]RSUs granted to the reporting person on July 9, 2023, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2023, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates